HemosIL Liquid Anti-Xa
Anti-Factor Xa Activity Test System, Apixaban. 510(k) K223187, from Instrumentation Laboratory CO (Bedford, MA). Product code QLU, class 2.
As of Nov 19, 2026, K223187 is an FDA 510(k) held by Instrumentation Laboratory CO, substantially equivalent on Jun 23, 2023 after 254 days, with no recalls tied to it in FDA's recall database.
- Review time: 254 days
- Recalls: 0
- Cited as a predicate by: 1 device
HemosIL Liquid Anti-Xa is an automated chromogenic assay for in vitro diagnostic use by laboratory professionals in clinical laboratories. The assay provides quantitative results on 3.2% citrated human plasma for the following analytes based on the calibrators used: • When used with HemosIL Heparin Calibrators: Quantitative determination of unfractionated heparin (UFH) and low molecular weight…
- HemosIL Liquid Anti-XaDEN190032 · Instrumentation Laboratory CO · Sep 17, 2020
- HemosIL Liquid Anti-XaK213464 · Instrumentation Laboratory CO · Oct 4, 2022
- INNOVANCE Anti-Xa (OPPU05); INNOVANCE Apixaban Standards (OPPW05); INNOVANCE Apixaban Controls (OPPS05)K240315 · Siemens Healthcare Diagnostics Products GmbH · Oct 10, 2024
- INNOVANCE Anti-Xa (OPPU05); INNOVANCE Apixaban Standards (OPPW05); INNOVANCE Apixaban Controls (OPPS05)K240315 · Siemens Healthcare Diagnostics Products GmbH · Oct 10, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Oct 12, 2022
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7295
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files